BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 15916792)

  • 21. Phenotypic Correlates of HIV-1 Macrophage Tropism.
    Arrildt KT; LaBranche CC; Joseph SB; Dukhovlinova EN; Graham WD; Ping LH; Schnell G; Sturdevant CB; Kincer LP; Mallewa M; Heyderman RS; Rie AV; Cohen MS; Spudich S; Price RW; Montefiori DC; Swanstrom R
    J Virol; 2015 Nov; 89(22):11294-311. PubMed ID: 26339058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a chemokine receptor CCR5-negative T cell line and its use in determining human immunodeficiency virus type 1 phenotype.
    Binninger-Schinzel D; Müller D; Wolf T; Krause B; Meye B; Winskowsky G; Raupp S; Norley S; Brodt R; Werner A
    J Med Virol; 2008 Feb; 80(2):192-200. PubMed ID: 18098144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of viral coreceptors and enhanced macrophage tropism in human immunodeficiency virus type 1 disease progression.
    Gorry PR; Sterjovski J; Churchill M; Witlox K; Gray L; Cunningham A; Wesselingh S
    Sex Health; 2004; 1(1):23-34. PubMed ID: 16335478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1.
    Reynes J; Portales P; Segondy M; Baillat V; André P; Réant B; Avinens O; Couderc G; Benkirane M; Clot J; Eliaou JF; Corbeau P
    J Infect Dis; 2000 Mar; 181(3):927-32. PubMed ID: 10720514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
    Marozsan AJ; Kuhmann SE; Morgan T; Herrera C; Rivera-Troche E; Xu S; Baroudy BM; Strizki J; Moore JP
    Virology; 2005 Jul; 338(1):182-99. PubMed ID: 15935415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent CCR5 utilization and enhanced macrophage tropism by primary blood human immunodeficiency virus type 1 isolates from advanced stages of disease and comparison to tissue-derived isolates.
    Li S; Juarez J; Alali M; Dwyer D; Collman R; Cunningham A; Naif HM
    J Virol; 1999 Dec; 73(12):9741-55. PubMed ID: 10559284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
    Swan CH; Bühler B; Steinberger P; Tschan MP; Barbas CF; Torbett BE
    Gene Ther; 2006 Oct; 13(20):1480-92. PubMed ID: 16738691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-macrophage interactions at the cellular and molecular level.
    Khati M; James W; Gordon S
    Arch Immunol Ther Exp (Warsz); 2001; 49(5):367-78. PubMed ID: 11798135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monocyte chemoattractant protein-2 (CC chemokine ligand 8) inhibits replication of human immunodeficiency virus type 1 via CC chemokine receptor 5.
    Yang OO; Garcia-Zepeda EA; Walker BD; Luster AD
    J Infect Dis; 2002 Apr; 185(8):1174-8. PubMed ID: 11930329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation.
    Lisco A; Grivel JC; Biancotto A; Vanpouille C; Origgi F; Malnati MS; Schols D; Lusso P; Margolis LB
    J Virol; 2007 Jan; 81(2):708-17. PubMed ID: 17065205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Varied tropism of HIV-1 isolates derived from different regions of adult brain cortex discriminate between patients with and without AIDS dementia complex (ADC): evidence for neurotropic HIV variants.
    Smit TK; Wang B; Ng T; Osborne R; Brew B; Saksena NK
    Virology; 2001 Jan; 279(2):509-26. PubMed ID: 11162807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood monocytes harbor HIV type 1 strains with diversified phenotypes including macrophage-specific CCR5 virus.
    Xu Y; Zhu H; Wilcox CK; van't Wout A; Andrus T; Llewellyn N; Stamatatos L; Mullins JI; Corey L; Zhu T
    J Infect Dis; 2008 Jan; 197(2):309-18. PubMed ID: 18173363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages.
    Peters PJ; Bhattacharya J; Hibbitts S; Dittmar MT; Simmons G; Bell J; Simmonds P; Clapham PR
    J Virol; 2004 Jul; 78(13):6915-26. PubMed ID: 15194768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of macrophage tropic HIV-1.
    Gorry PR; Churchill M; Crowe SM; Cunningham AL; Gabuzda D
    Curr HIV Res; 2005 Jan; 3(1):53-60. PubMed ID: 15638723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 clade C envelopes obtained from late stage symptomatic Indian patients varied in their ability towards relative CD4 usages and sensitivity to CCR5 antagonist TAK-779.
    Gharu L; Ringe R; Bhattacharya J
    Virus Res; 2011 Jun; 158(1-2):216-24. PubMed ID: 21524671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1.
    Tuttle DL; Harrison JK; Anders C; Sleasman JW; Goodenow MM
    J Virol; 1998 Jun; 72(6):4962-9. PubMed ID: 9573265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased HIV-DNA load in CCR5-negative lymphocytes without viral phenotypic change.
    Pakarasang M; Wasi C; Suwanagool S; Chalermchockcharoenkit A; Auewarakul P
    Virology; 2006 Apr; 347(2):372-8. PubMed ID: 16412490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate.
    Gorry PR; Taylor J; Holm GH; Mehle A; Morgan T; Cayabyab M; Farzan M; Wang H; Bell JE; Kunstman K; Moore JP; Wolinsky SM; Gabuzda D
    J Virol; 2002 Jun; 76(12):6277-92. PubMed ID: 12021361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS.
    Sterjovski J; Churchill MJ; Ellett A; Gray LR; Roche MJ; Dunfee RL; Purcell DF; Saksena N; Wang B; Sonza S; Wesselingh SL; Karlsson I; Fenyo EM; Gabuzda D; Cunningham AL; Gorry PR
    Retrovirology; 2007 Dec; 4():89. PubMed ID: 18076768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apical interactions of HIV type 1 with polarized HEC-1 cell monolayer modulate R5-HIV type 1 spread by submucosal macrophages.
    Saïdi H; Magri G; Carbonneil C; Bouhlal H; Hocini H; Belec L
    AIDS Res Hum Retroviruses; 2009 May; 25(5):497-509. PubMed ID: 19397398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.